u/kasper_cabrera

Has anyone posted an independent purity result for this compound?

Assumed the weight numbers were the point and was corrected. They are secondary to what this is being developed for.

Right — HJ publishes the method line on the certificate, and once you have seen one that does you notice every one that does not.

maintenance is a phase, not a finish line

Fixing my own comment above: I said 21 orders and it is 26. The pattern is the same, the count was wrong.

the second-level appeal is where things actually turn

external review exists and almost nobody uses it

Withdrawal studies in this class consistently show substantial regain after discontinuation. That is a pharmacological finding about a chronic condition, not a statement about anyone’s discipline.

Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.

ask for the batch record before you ask for a discount

Spent six weeks arguing in general terms and got nowhere. Two paragraphs quoting their own criteria turned it around in eleven days.

nobody here is paid, including the moderators

the fasting number is the one people fixate on and it moves last

Proposed a rule change here with actual wording and it was adopted. That is the process working and it is not fast.

Disagree with loosening that. The evidence rule is why a supplier report here means something.

Disagree — that is an obesity trial endpoint and this thread is about glycaemic control.

Has appetite changed, or only the scale?

Mild pushback: a supplier with fewer entries is not worse, it is less sampled. Those are different claims and the table says so.

dual GLP-1 and glucagon agonist, and the glucagon arm is the story

Correction: that trial measured regain after withdrawal, not failure of the drug during treatment. Very different claim.

Yes — nothing containing this is approved anywhere, which is the first fact and usually the last one mentioned.

Employer plan or individual plan?

What a batch record should carry: the lot identifier, the date of analysis, the method including column and gradient, the individual related substances rather than a total, and the storage condition the stability statement was written against.

Left up.

Adding the practical version: ask for lead time, minimum quantity and the batch record in the same message. Three answers, one email.

Agree. The verification log is the part with the checkable facts in it; the number at the top is just a summary of a lot of averaging.

the wiki is editable by anybody with standing on the site

Weigh monthly now. Best change I made in the whole run and it cost nothing.

Went slowly because everything published describes a deliberate escalation. That is the extent of what I will say about it.

Same view. The second-level appeal is where mine turned, after a first-level denial that looked final.

Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.

the source page log is more useful than the score above it

seven days to ten to twelve is the sequence people here describe

None of this is a taper plan. What dose holds for you is a question for somebody with your history in front of them.

Tracking number redacted from the post above.

Adding the practical version: ask for lead time, minimum quantity and the batch record in the same message. Three answers, one email.

The escalation schedules in the published protocols are slow and deliberate, and the tolerability tables show why. That is a description of the trials rather than a suggestion for anybody.

lead time quoted at checkout is the number to hold them to

biopsy-confirmed is not the same as imaging-suggested

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

modmail first, always, and the thread second

This is the principle the whole site is built on. Publish it or do not enforce it.

Correction: that is the imaging endpoint, not the histological one. The paper reports both and they differ substantially.